Asia Pacific Metagenomics Market to 2027 - Regional Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Country
Publication Month: Feb 2019
Report Code: TIPRE00003320 No. of Pages: 141 Category: Biotechnology Status: Published
The Asia pacific Metagenomics market is expected to reach US$ 61.9 Mn in 2027 from US$ 30.6 Mn in 2018. The market is estimated to grow with a CAGR of 8.5% from 2018-2027.
The growth of the market is driven by the factors such as increasing demand for genomics, growing demand for metagenomics over traditional methods and various applications of metagenomics, in the Asia pacific region. Whereas, expensive techniques of metagenomics is likely to have a negative impact on the growth of the market in the coming years.
In Asia Pacific, the government is supporting more for the genomics and with the support from the government the Chinese players are investing more into the genetic research. The genomics in this region is booming due to the increasing demand for the genetic sequencing. The rise in the Asia’s genomics market is driven by the factors such as rise in the geriatric population, significant growth of the healthcare system and rise in the income of the population. The Chinese government has made compulsion for the data banking of its citizens, the population’s includes genomic data of the people. In addition, a data provided by the Chinese genetics leader BGI states that in China market size of the genetic testing has grown by five times of a market share which is approximately to US$ 925 billion in between 2012 to 2016. Moreover, near around 330 million people of age of 65years and above are anticipated in 2025, therefore the rise in the personalized medicine is expected to grow the market in coming future. Also, investments in the field of genomics is rising For instance, in 2016, the Chinese Academy of Sciences had launched the initiative for precision medicine. Whereas it invested approximately US$ 9 billion to a project that will sequence over 100 million human genomes by 2030. Recently in December 2017, the China’s Ministry of Science and Technology has joined with a human genome research project to document the genetic makeup of 25,000 people.
Owing to growing demand for genomics by the market leaders that enables the access to the metagenomics studies are likely to propel the growth of the market in the forecast period.
China is anticipated to lead the adoptions of Metagenomics across the Asia Pacific region through the forecast period. The metagenomic market in china is anticipated to witness significant growth in the forecast period owing to the extensive conduction of metagenomics. For instance. a project titled as ‘Metagenomic Analysis of Flaviviridae in Mosquito Viromes Isolated From Yunnan Province in China Reveals Genes From Dengue and Zika Viruses’ was conducted. This project was funded by some Chinese entities which include the National Program on Key Research Project of China, Special Fund for Agro-scientific Research in the Public Interest, National Natural Science Foundation of China and others. This project utilized Illumina sequencing to conclude its results.
ASIA PACIFIC METAGENOMICS - MARKET SEGMENTATION
By Product
• Instruments & Software
• Consumables
ASIA PACIFIC METAGENOMICS - MARKET SEGMENTATION
By Application
• Clinical Diagnostics
• Drug Discovery
By Country
• China
• India
• Japan
Companies Mentioned
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Agilent Technologies
• Qiagen
• Bio-Rad Laboratories, Inc.
• Perkinelmer Inc.
• Illumina Inc.
• F Hoffman-La Roche Ltd.
• Oxford Nanopore Technologies Ltd.
• Pacific Bioscience of California, Inc.
The growth of the market is driven by the factors such as increasing demand for genomics, growing demand for metagenomics over traditional methods and various applications of metagenomics, in the Asia pacific region. Whereas, expensive techniques of metagenomics is likely to have a negative impact on the growth of the market in the coming years.
In Asia Pacific, the government is supporting more for the genomics and with the support from the government the Chinese players are investing more into the genetic research. The genomics in this region is booming due to the increasing demand for the genetic sequencing. The rise in the Asia’s genomics market is driven by the factors such as rise in the geriatric population, significant growth of the healthcare system and rise in the income of the population. The Chinese government has made compulsion for the data banking of its citizens, the population’s includes genomic data of the people. In addition, a data provided by the Chinese genetics leader BGI states that in China market size of the genetic testing has grown by five times of a market share which is approximately to US$ 925 billion in between 2012 to 2016. Moreover, near around 330 million people of age of 65years and above are anticipated in 2025, therefore the rise in the personalized medicine is expected to grow the market in coming future. Also, investments in the field of genomics is rising For instance, in 2016, the Chinese Academy of Sciences had launched the initiative for precision medicine. Whereas it invested approximately US$ 9 billion to a project that will sequence over 100 million human genomes by 2030. Recently in December 2017, the China’s Ministry of Science and Technology has joined with a human genome research project to document the genetic makeup of 25,000 people.
Owing to growing demand for genomics by the market leaders that enables the access to the metagenomics studies are likely to propel the growth of the market in the forecast period.
China is anticipated to lead the adoptions of Metagenomics across the Asia Pacific region through the forecast period. The metagenomic market in china is anticipated to witness significant growth in the forecast period owing to the extensive conduction of metagenomics. For instance. a project titled as ‘Metagenomic Analysis of Flaviviridae in Mosquito Viromes Isolated From Yunnan Province in China Reveals Genes From Dengue and Zika Viruses’ was conducted. This project was funded by some Chinese entities which include the National Program on Key Research Project of China, Special Fund for Agro-scientific Research in the Public Interest, National Natural Science Foundation of China and others. This project utilized Illumina sequencing to conclude its results.
Exhibit: Rest of Asia Pacific Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
ASIA PACIFIC METAGENOMICS - MARKET SEGMENTATION
By Product
• Instruments & Software
• Consumables
ASIA PACIFIC METAGENOMICS - MARKET SEGMENTATION
By Application
• Clinical Diagnostics
• Drug Discovery
By Country
• China
• India
• Japan
Companies Mentioned
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Agilent Technologies
• Qiagen
• Bio-Rad Laboratories, Inc.
• Perkinelmer Inc.
• Illumina Inc.
• F Hoffman-La Roche Ltd.
• Oxford Nanopore Technologies Ltd.
• Pacific Bioscience of California, Inc.
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. Asia pacific Metagenomics Market – Key takeaways
PART 3. Asia pacific Metagenomics market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 Asia pacific Metagenomics Market – By Product
3.2.2 Asia pacific Metagenomics Market – By Application
3.2.3 Asia pacific Metagenomics Market – By Country
3.3 PEST Analysis
3.3.1 Asia pacific – PEST Analysis
PART 4. Asia pacific Metagenomics market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Investments in the field of Metagenomics
4.1.2 Benefits of Metagenomics Over Traditional Methods
4.1.3 Diverse Potential Applications of Metagenomics
4.2 Key Market Restraints
4.2.1 High Cost Associated With Metagenomics
4.3 Key Market Opportunities
4.3.1 Precision Metagenomic Analysis In Personalised Medicine
4.4 Key Market Trends
4.4.1 Growing Trend of Molecular-Based Approaches
4.5 Impact analysis
PART 5. Metagenomics market – Asia pacific Analysis
5.1 Asia pacific Metagenomics market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
Illumina, Inc.
Qiagen
5.4 expert opinions
PART 6. Asia pacific Metagenomics market Analysis – By Product
6.1 Overview
6.2 ASIA PACIFIC metagenomics MARKET, BY product, 2018 & 2027 (%)
6.3 Asia pacific Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
6.4 Instruments & Software Market
6.4.1 Overview
6.4.2 Asia pacific Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Consumables Market
6.5.1 Overview
6.5.2 Asia pacific Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
PART 7. Asia pacific Metagenomics market Analysis – By Application
7.1 Overview
7.2 ASIA PACIFIC Metagenomics MARKET, BY application, 2018 & 2027 (%)
7.3 Clinical Diagnostic Market
7.3.1 Overview
7.3.2 Asia pacific Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Drug Discovery metagenomics Market
7.4.1 Overview
7.4.2 Asia pacific Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Others Market
7.5.1 Overview
7.5.2 Asia pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
PART 8. Asia pacific Metagenomics market Revenue and Forecasts to 2027
8.1 Overview
8.2 Asia pacific metagenomics Market Revenue And Forecasts to 2027, By Country (%)
8.3 US Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)
8.3.1 US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.2 US Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.3 US Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.4 Canada Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)
8.4.1 Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.2 Canada Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.4.3 Canada Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.5 Mexico Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)
8.5.1 Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.2 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.5.3 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
PART 9. Metagenomics Market –Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Metagenomics Market, 2015-2018
9.3 Organic Developments
9.3.1 Overview
9.4 Organic Growth Strategies in the METAGENOMICS Market, 2015-2018
9.5 Product Launch
9.5.1 Recent Product Launch By Players In The Metagenomics Market
9.6 Product approval
9.6.1 Recent Product Approval By Players In The Metagenomics Market
9.7 Expansion & Others
9.7.1 The Metagenomics Market By Expansion & Other Growth Strategies
9.8 Inorganic developments
9.8.1 Overview
9.9 inOrganic Growth Strategies in the Metagenomics Market, 2015-2018
9.10 Acquisitions
9.10.1 Acquisitions By Players In The Metagenomics Market
9.11 Agreements
9.11.1 The Metagenomics Market By Agreements
9.12 Partnership & Collaboration
9.12.1 Partnership By Players In The Metagenomics Market
PART 10. Metagenomics Market–Key company profiles
10.1 Merck KGaA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Thermo Fisher Scientific, Inc.
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Information
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Agilent Technologies, Inc.
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 QIAGEN
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Overview
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Bio-Rad Laboratories, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Perkin Elmer, inc.
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Illumina, Inc.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 F. Hoffmann-La Roche Ltd.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Oxford Nanopore Technologies Ltd.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product & Services Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Pacific Bioscience of California, inc.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product & Services Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
PART 11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
LIST OF TABLES
TABLE 1. Asia pacific Metagenomics market Revenue And Forecasts to 2025, By product (US$ Mn)
TABLE 2. US Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 3. US Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 4. Canada Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 5. Canada Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 6. Mexico Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 7. Mexico Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 8. Recent Product Launch in the Metagenomics Market
TABLE 9. Recent Product Approval and Enhancements in the Metagenomics Market
TABLE 10. the Metagenomics Market by Exansion & Others Strategies
TABLE 11. Acquisitions in the Metagenomics Market
TABLE 12. the Metagenomics Market by Agreements
TABLE 13. partnership in the Metagenomics Market
TABLE 14. Glossary of Terms, Metagenomics market
LIST OF FIGURES
FIGURE 1. US Metagenomics market, Revenue (US$ Mn), By 2018 & 2027
FIGURE 2. Asia pacific Metagenomics Market By product, Market Share (%), 2018
FIGURE 3. Asia pacific Metagenomics Market By application, Market Share (%), 2018
FIGURE 4. Metagenomics market Segmentation
FIGURE 5. Asia pacific PEST Analysis
FIGURE 6. Metagenomics market impact analysis of drivers & Restraints
FIGURE 7. Asia pacific Metagenomics market – Revenue Forecasts and Analysis – 2017- 2027
FIGURE 8. Asia pacific metagenomics market By Product, 2018 & 2027 (%)
FIGURE 9. Asia pacific Instruments & software Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 10. Asia pacific Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 11. Asia pacific Metagenomics market By application, 2018 & 2027 (%)
FIGURE 12. Asia pacific Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 13. Asia pacific Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 14. Asia pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 15. Asia pacific Metagenomics Market REVENUE, by Country, 2018 (US$ MN)
FIGURE 16. US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 17. Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 18. Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 19. Growth Strategies in the Metagenomics Market, 2015-2018
FIGURE 20. Organic Growth Strategies in the METAGENOMICS Market, 2015-2018
FIGURE 21. Inorganic developments in the Metagenomics Market, 2015-2018
The List of Companies
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Agilent Technologies
- Qiagen
- Bio-Rad Laboratories, Inc.
- Perkinelmer Inc.
- Illumina Inc.
- F Hoffman-La Roche Ltd.
- Oxford Nanopore Technologies Ltd.
- Pacific Bioscience of California, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the metagenomics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global metagenomics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.